Buchan, Andra
Wiedman, Stephanie
Lambirth, Kevin
Bellanger-Perry, Madeline
Figueroa, Jose L. III
Wright, Elena T.
Suresh, Patil Shivprasad
Zhang, Qibin
Thomas, Julie A.
Serwer, Philip
White, Richard Allen III
Article History
Received: 5 February 2025
Accepted: 29 August 2025
First Online: 30 September 2025
Competing interests
: The authors declare no conflicts of interest. RAW is the CEO of RAW Molecular Systems (RAW), LLC, but no financial, IP, or others from RAW LLC were used or contributed to the study.